OBJECTIVE: To review the definition, clinical presentation, and management of inflammatory breast cancer in primary care. SOURCES OF INFORMATION: Relevant research and review articles, as well as personal experience of the authors practising in a specialized locally advanced breast cancer program at a comprehensive cancer centre. Evidence is levels II and III. MAIN MESSAGE: Inflammatory breast cancer is a rare disease that typically presents with a rapidly enlarging erythematous breast, often with no discernable breast mass. Identification of warning signs and recognition of clinical symptoms are crucial to prompt diagnosis and appropriate referral. Management in the primary care setting includes treatment of symptoms, psychosocial support, regular surveillance and follow-up, as well as palliative care. CONCLUSION: Family physicians are usually the entry point to the health care system and are well positioned to assess inflammation of the breast and recognize the warning signs of an underlying inflammatory breast cancer. They are also important members of the team that provides support for breast cancer patients and their families during treatment, follow-up, and end-of-life care.
OBJECTIVE: To review the definition, clinical presentation, and management of inflammatory breast cancer in primary care. SOURCES OF INFORMATION: Relevant research and review articles, as well as personal experience of the authors practising in a specialized locally advanced breast cancer program at a comprehensive cancer centre. Evidence is levels II and III. MAIN MESSAGE: Inflammatory breast cancer is a rare disease that typically presents with a rapidly enlarging erythematous breast, often with no discernable breast mass. Identification of warning signs and recognition of clinical symptoms are crucial to prompt diagnosis and appropriate referral. Management in the primary care setting includes treatment of symptoms, psychosocial support, regular surveillance and follow-up, as well as palliative care. CONCLUSION: Family physicians are usually the entry point to the health care system and are well positioned to assess inflammation of the breast and recognize the warning signs of an underlying inflammatory breast cancer. They are also important members of the team that provides support for breast cancerpatients and their families during treatment, follow-up, and end-of-life care.
Authors: Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine Journal: J Natl Cancer Inst Date: 2005-07-06 Impact factor: 13.506
Authors: Thomas A Buchholz; Susan L Tucker; Lawrence Masullo; Henry M Kuerer; Jessica Erwin; Jessica Salas; Debbie Frye; Eric A Strom; Marsha D McNeese; George Perkins; Angela Katz; S Eva Singletary; Kelly K Hunt; Aman U Buzdar; Gabriel N Hortobagyi Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544
Authors: Jennifer A Low; Arlene W Berman; Seth M Steinberg; David N Danforth; Marc E Lippman; Sandra M Swain Journal: J Clin Oncol Date: 2004-10-15 Impact factor: 44.544
Authors: Nabila Chaher; Hugo Arias-Pulido; Nadija Terki; Clifford Qualls; Kamel Bouzid; Claire Verschraegen; Anne Marie Wallace; Melanie Royce Journal: Breast Cancer Res Treat Date: 2011-03-01 Impact factor: 4.872
Authors: Catherine Bingham; Sandra V Fernandez; Patricia Fittipaldi; Paul W Dempsey; Karen J Ruth; Massimo Cristofanilli; R Katherine Alpaugh Journal: Breast Cancer Res Treat Date: 2017-03-07 Impact factor: 4.872
Authors: Tithi Biswas; Charulata Jindal; Timothy L Fitzgerald; Jimmy T Efird Journal: Int J Environ Res Public Health Date: 2019-01-04 Impact factor: 3.390
Authors: Israa Salem; Manal Alsalahi; Inna Chervoneva; Lucy D Aburto; Sankar Addya; Gregory R Ott; Bruce A Ruggeri; Massimo Cristofanilli; Sandra V Fernandez Journal: Breast Cancer Res Date: 2016-03-24 Impact factor: 6.466